Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

2.650 +2.500 (+1666.67%)

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sunshine Biopharma Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

March 24, 2025

Via ACCESS Newswire

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

March 10, 2025

Via ACCESS Newswire

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

January 21, 2025

Via ACCESS Newswire

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

January 15, 2025

Via ACCESSWIRE

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

December 09, 2024

Via ACCESSWIRE

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

September 04, 2024

Via ACCESSWIRE

Sunshine Biopharma Launches a New Generic Prescription Drug

December 04, 2024

Via ACCESSWIRE

Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

December 02, 2024

Via ACCESSWIRE

Sunshine Biopharma Launches a New Generic Prescription Drug

November 22, 2024

Via ACCESSWIRE

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

November 06, 2024

Via ACCESSWIRE

Sunshine Biopharma Launches Two New Generic Prescription Drugs

September 26, 2024

Via ACCESSWIRE

New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

September 04, 2024

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END

Via FinancialNewsMedia

Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

September 04, 2024

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

September 04, 2024

From FN Media Group LLC

Via GlobeNewswire

SUNSHINE BIOPHARMA ANNOUNCES PUBLICATION OF SIGNIFICANT CORONAVIRUS RESEARCH RESULTS IN THE JOURNAL OF MEDICINAL CHEMISTRY

September 04, 2024

Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18% Development of a novel antiviral compound, XR8-23 (Compound 10), targeting SARS-CoV-2 papain-like protease (PLpro) with both...

Via FinancialNewsMedia

Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

September 04, 2024

From FN Media Group LLC

Via GlobeNewswire

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

August 26, 2024

Via ACCESSWIRE

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

August 19, 2024

Via ACCESSWIRE

SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024 ↗

August 16, 2024

SBFM stock results show that Sunshine Biopharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Sunshine Biopharma Announces Reverse Stock Split

August 06, 2024

Via ACCESSWIRE

7 F-Rated Growth Stocks to Avoid Right Now: June 2024 ↗

June 28, 2024

A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.

Via InvestorPlace

3 Penny Stocks Ready to Explode Into Dollar Signs by 2028 ↗

June 20, 2024

The best penny stocks to buy are those you can understand and stomach the exceptional risks of in order to profit.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 10, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 10, 2024

Via Benzinga

Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 10, 2024

Via Benzinga

Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket ↗

June 10, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 07, 2024

Via Benzinga

Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%

May 21, 2024

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.